BiotechTubeBiotechTube
Home/Aspen Pharmacare/Reginald Haman
RH

Reginald Haman

Executive Director (Group Enablement)

Aspen Pharmacare

Therapeutic Areas

AnaestheticsThrombosisOncologyAutoimmune DiseasesPediatric NutritionGeneral Medicine

Aspen Pharmacare Pipeline

DrugIndicationPhase
Anaesthetics PortfolioPerioperative careApproved
Thrombosis Portfolio (e.g., Arixtra® generics)Prevention/treatment of blood clotsApproved
High Potency & Cytotoxic SterilesOncology & supportive careApproved
Biosimilars (e.g., trastuzumab, rituximab)Oncology, Autoimmune diseasesApproved
Infant NutritionalsPediatric nutritionApproved
General OTC & Prescription BrandsVarious (Pain, Allergy, GI)Approved

Leadership Team at Aspen Pharmacare

SS
Stephen Saad
Group Chief Executive
SC
Sean Capazorio
Group Chief Financial Officer
KD
Kuseni Dlamini
Independent Non-executive Director, Board Chair
BK
Ben Kruger
Lead Independent Non-executive Director
LD
Linda de Beer
Independent Non-executive Director
ND
Neo Dongwana
Independent Non-executive Director
TM
Themba Mkhwanazi
Independent Non-executive Director
CM
Chris Mortimer
Independent Non-executive Director
YM
Yvonne Muthien
Independent Non-executive Director
DR
David Redfern
Independent Non-executive Director
View full Aspen Pharmacare profile